Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 108727

In scope icon M 7 D
QID 108727 (Type "108727" in App Search)
A 36-year-old G3P2 at 11 weeks of gestation presents to the emergency department for a rash. She reports that she started feeling unwell several weeks ago but attributed her symptoms of anxiety and sweating to her pregnancy. The patient reports that she has been feeling anxious about issues that had never bothered her before such as getting her toddler to preschool on time. She also has found herself sweating more than usual when everyone else around her seems to be comfortable. At her most recent appointment with her obstetrician, she was noted to have lost 4 pounds from her appointment 2 weeks prior. In the course of the workup for her symptoms, a thyrotropin-stimulating immunoglobulin assay was positive. The patient reports that her obstetrician gave her 2 medications for her condition that she began taking yesterday. She first noticed the rash before she went to sleep and it started to bother her more and more throughout the night. Her temperature is 98.0°F (36.7°C), blood pressure is 109/68 mmHg, pulse is 113/min, and respirations are 15/min. Her rash can be seen in Figure A. After discontinuing her current medications the most appropriate next step in management has which of the following complications?
  • A
  • A